Desk›Healthcare› Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd
BSE 539470 · NSE SHREEGANES · ISIN INE051N01026 · Group X · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Biotechnology
₹0.50
-1.96%
BSE close, 28 August 2026
₹19.93 cr
39.9 cr shares · Micro cap
₹19.93 cr
as published
-50.0× · 0.31×
EPS ₹-0.01 · BV ₹1.61
4.97 / 0.38
₹ cr, as filed
12
2 selected · 17%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -37.5% |
|---|---|
| Against 52-week low | +2.0% |
| Day change | -1.96% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.01 |
|---|---|
| Price / earnings | -50.00× |
| Price / book | 0.31× |
| Book value — derived, price ÷ P/B | ₹1.61 |
| Return on equity | -0.61% |
| Operating margin | -40.07% |
| Net margin | -40.07% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -0.62%
- ROE as published
- -0.61%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 1.43 | -0.57 | -0.01 | -40.07% | -40.07% |
| Mar-26 · Q | 2.12 | -0.15 | — | -6.98% | -7.02% |
| FY25-26 | 4.97 | 0.38 | 0.01 | 10.36% | 7.60% |
Quarter on quarter
- Revenue, quarter on quarter
- -32.5%
- Net profit, quarter on quarter
- -280.0%
- Operating margin, quarter on quarter
- -3,309 bps
Disclosure profile 12 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| AGM / EGM | 3 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Book Closure | 1 |
| Compliance Certificate | 1 |
| General | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 10 |
| Total | 12 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
12 filings · 2 selected · busiest 2026-08-04 and 2026-09-03
Filing rhythm · the twelve most recent
2026-07-212026-10-06
SelectedProcedural
Filings
12 in the window · 2 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
28 September 2026 ·
-
28 September 2026 ·
-
17 September 2026 ·
-
3 September 2026 ·
Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial ....
Others / Reg. 34 (1) Annual Report View filing →
-
3 September 2026 ·
Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
PFA
Corp. Action / Book Closure View filing →
-
3 September 2026 ·
Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
PFA
AGM/EGM / AGM View filing →
-
1 September 2026 ·
-
4 August 2026 ·
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
PFA
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
4 August 2026 ·
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
PFA
Result / Financial Results View filing →
-
4 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026.
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....
Board Meeting / Outcome of Board Meeting View filing →
-
21 July 2026 ·
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
Shree Ganesh Biotech (India) Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Board Meeting / Board Meeting View filing →
RSS feed for Shree Ganesh Biotech (India) Ltd · the 50 most recent filings